Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and Hong Kong. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine; generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Research context
Lansen Pharmaceutical Holdings Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Lansen Pharmaceutical Holdings Limited is currently in a long term uptrend where the price is trading 67.0% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Lansen Pharmaceutical Holdings Limited's total revenue sank by 4.7% to $27M since the same quarter in the previous year.
Its net income has increased by 610.9% to $96M since the same quarter in the previous year.
Finally, its free cash flow grew by 302.3% to $3M since the same quarter in the previous year.
Based on the above factors, Lansen Pharmaceutical Holdings Limited gets an overall score of 4/5.